"REGULATORY NUCLEIC ACID FOR THE ABC1 GENE, MOLECULES MODIFYING ITS ACTIVITY AND THERAPEUTIC USES"
Application IN/PCT/2002/01082/DEL published 2007-04-06, filed 2002-10-31
The present invention concerns a nucleic acid which is capable of regulating the transcription of the ABCl gene, which is a causal gene for pathologies linked to adysfunctioning of cholesterol metabolism, inducing diseases such as atherosclerosis. The invention also relates to nucleotide constructs comprising a polynucleotide which encodes a polypeptide or a nucleic acid of interest, placed under the control a regulatory nucleic acid for the ABCl gene. The invention also relates to recombinant vectors, transformed host cells and nonhuman transgenic mammals comprising a nucleic acid which regulates the transcription of the ABCl gone or an abovementioned nucleotide construct, as well as methods for screening molecules or substances which are capable of modifying the activity of the regulatory nucleic acid for the ABCl gene.
Applicant
1)AVENTIS PHARMA S.A.
:20, AVENUE RAYMOND-ARON, F-92160 ANTONY, FRANCE. France
Inventor
1)MARIE-FRANCOISE ROSIER-MONTUS 2)CATHERINE PRADES 3)CENDRINE LEMOINE 4)LAURENT NAUDIN 5)PATRICE DENEFLE 6)BRYAN H. BREWER 7)NICOLAS DUVERGER 8)ALAN REMALEY 9)SILVIA SANTAMARINA-FOJO No of Pages : 128 No of Claims : 56
International Info
Classification: C12N 15/12
Publication Number: WO 01/83746
Application Date: 2001-05-02
Priority Information
60/201,280 U.S.A. 2000-05-02